Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.

@article{Zelefsky2000ClinicalEW,
  title={Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer.},
  author={Michael J Zelefsky and Zvi Y Fuks and Laura Happersett and Hak Jong Lee and C. Clifton Ling and Chandra M. Burman and Margie S Hunt and Timothy Wolfe and Ennapadam S Venkatraman and Andrew Jackson and Mark W. Skwarchuk and Steven A. Leibel},
  journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  year={2000},
  volume={55 3},
  pages={241-9}
}
PURPOSE To compare acute and late toxicities of high-dose radiation for prostate cancer delivered by either conventional three-dimensional conformal radiation therapy (3D-CRT) or intensity modulated radiation therapy (IMRT). MATERIALS AND METHODS Between September 1992 and February 1998, 61 patients with clinical stage T1c- T3 prostate cancer were treated with 3D-CRT and 171 with IMRT to a prescribed dose of 81 Gy. To quantitatively evaluate the differences between conventional 3D-CRT and… CONTINUE READING